Table 5.
Compound | EGFR | BRAFV600E | ||
---|---|---|---|---|
Docking Scores (kcal/mol) | Binding Features | Docking Scores (kcal/mol) | Binding Features a | |
3a | −8.0 | CYS773 (2.21 Å) | −8.4 | LYS483 (2.15 Å), THR529 (2.38 Å), ASP594 (2.12 Å) |
3c | −7.9 | CYS773 (2.15 Å) | −7.8 | LYS483 (2.13 Å) ASP594 (1.93 Å) |
3d | −8.1 | CYS773 (2.17 Å) | −8.5 | LYS483 (1.93 Å), GLY596 (2.32 Å), THR529 (2.66 Å), ASP594 (2.14 Å) |
3f | −8.5 | CYS773 (2.18 Å) | −8.7 | LYS483 (2.15 Å), THR529 (2.38 Å), ASP594 (2.12 Å) |
Erlotinib | −8.6 | MET769 (1.62 Å), CYS773 (1.91 Å) |
−8.4 | THR529 (2.07), CYS532 (2.02) |
a Only hydrogen bonds are presented in Å.